Bupropion as a modulator of drug activity | Patent Publication Number 20210000768

US 20210000768 A1

Patent NumberUS 10966942 B2

Application Number17025849

Filled DateSep 18, 2020

Priority DateJan 7, 2019

Publication DateJan 7, 2021

Original AssigneeAxsome Therapeutics Inc.

Current AssigneeAntecip Bioventures Ii Llc Axsome

Inventor/ApplicantsHerriot Tabuteau

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.